Broccoli sprouts powder could improve serum triglyceride and oxidized LDL/LDL-cholesterol ratio in type 2 diabetic patients: A randomized double-blind placebo-controlled clinical trial

Diabetes Research and Clinical Practice

Volumn 96, Issue 3, 2012, Pages 348-354

  Bahadoran, Zahra ^a,e   Mirmiran, Parvin ^b,e   Hosseinpanah, Farhad ^a   Rajab, Asadolah ^c,e   Asghari, Golale ^a,e   Azizi, Fereidoun ^d,e  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c Iran Diabetes Society   (Iran)

^d SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e NONE   (Iran)

Author keywords

Broccoli sprouts; Lipid profiles; Oxidized LDL cholesterol; Type 2 diabetes

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OXIDIZED LOW DENSITY LIPOPROTEIN; PLACEBO; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; BROCCOLI; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET RESTRICTION; DIET SUPPLEMENTATION; DIETARY INTAKE; DISEASE DURATION; DOUBLE BLIND PROCEDURE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PARALLEL DESIGN; POWDER; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK FACTOR; SPROUT; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 84862204663     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2012.01.009     Document Type: Article

References (36)

1. Gadi R., Samaha F.F. Dyslipidemia in type 2 diabetes mellitus. Curr Diab Rep 2007, 7(3):228-234.
2. Taskinen M.R. Type 2 diabetes as a lipid disorder. Curr Mol Med 2005, 5(3):297-308.
3. Santaguida P.L., Balion C., Hunt D. Diagnosis, prognosis, and treatment of impaired glucose tolerance and impaired fasting glucose. Evid Rep Technol Assess 2008, 12(8):1-11.
4. Davi G., Sanitilli F., Patrono C. Nutraceutical in diabetes and metabolic syndrome. Cardiovasc Ther 2010, 28(4):216-226.
5. Dembinska-Kiec A., Mykkänen O., Kiec-Wilk B., Mykkänen H. Antioxidant phytochemicals against type 2 diabetes. Br J Nutr 2008, 99(1):ES109-ES117.
6. Jeffery E., Araya M. Physiological effects of broccoli consumption. Phytochem Rev 2009, 8:283-298.
7. Keum Y., Jeong W., Kong T. Chemoprevention by isothiocyanates and underlying molecular signaling mechanisms. Mutat Res 2004, 555:191-192.
8. Verkerk R., Schreiner M., Krumbein A., Ciska E., Holst B., Rowland I., et al. Glucosinolates in brassica vegetable: the influence of the food supply chain on intake, bioavailability and human health. Mol Nutr Food Res 2009, 53(Suppl. 2):S219-S266.
9. Lee J., Shin H., Lee Y., Kim A., Lee M. Effect of broccoli sprouts on cholesterol-lowering and anti-obesity effects in rats fed high fat diet. J Korean Soc Food Sci Nutr 2009, 38(3):309-318.
10. Moreno D.A., Carvajal M., López-Berenguer C., García-Viguera C. Chemical and biological characterisation of nutraceutical compounds of broccoli. J Pharm Biochem Anal 2006, 41:1508-1522.
11. Riedl M.A., Saxon A., Diaz-Sanchez D. Oral sulforaphane increases phase II antioxidant enzymes in the human upper airway. Clin Immunol 2009, 130(3):244-251.
12. Fahey J., Talalay P. Antioxidant function of sulforaphane: a potent inducer of phase 2 detoxyfication enzymes. Food Chem Toxicol 1999, 37:973-979.
13. Murashima M., Watanabe S., Zhuo X.G., Uehara M., Kurashige A. Phase 1 study of multiple biomarkers for metabolism and oxidative stress after one-week intake of broccoli sprouts. Biofactors 2004, 22(1-4):271-275.
14. Schulz K.F., Altman D.G., Moher D. CONSORT 2010 statement. Updated guidelines for reporting parallel group randomized trials. J Clin Epidemiol 2010, 63(8):834-840.
15. The Nutrient Data Laboratory. Food Composition Table (FCT), Food and Nutrition Information Center, United State Department of Agriculture (USDA). http://www.nal.usda.gov/fnic/foodcomp.
16. Azar M., Sarkisian E. Food composition table of Iran. National Nutrition and Food Research Institute 1980, Shahid Beheshti University Press.
17. Cordova C.M., Schneider C.R., Juttle I.D., Cordova M.M. Comparison of LDL-cholesterol direct measurement with the estimate using the friedewald formula in a sample of 10664 patients. Arq Bras Cardiol 2004, 83(6):482-487.
18. Sarwar N., Danesh J., Eiriksdottir G., Sigurdsson G., Wareham N., Bingham S., et al. Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 participants in 29 Western prospective studies. Circulation 2007, 115(4):450-458.
19. Hokanson J.E., Austin M.A. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk 1996, 3(2):213-219.
20. Nicolucci A., De Berardis G., Sacco M., Tognoni G. Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association. Diabetes Care 2007, 30:162-172.
21. Jialal I., Amess W., Kaur M. Management of hypertriglyceridemia in the diabetic patient. Curr Diab Rep 2010, 10(4):316-320.
22. Birjmohun R.S., Hutten B.A., Kastelein J.J., Stroes E.S. Efficacy and safety of high-density lipoprotein cholesterol-increasing compounds: a meta-analysis of randomized controlled trials. J Am Coll Cardiol 2005, 45(2):185-197.
23. Colhoun H.M., Betteridge D.J., Durrington P.N., Hitman G.A., Neil H.A., Livingstone S.J., et al. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet 2004, 364(August (9435)):685-696.
24. Shimada K., Mokuno H., Matsunaga E., Miyazaki T., Sumiyoshi K., Kume A., et al. Predictive value of circulating oxidized LDL for cardiac events in type 2 diabetic patients with coronary artery disease. Diabetes Care 2004, 27(3):843-844.
25. Galland F., Duvillard L., Petit J.M., Lagrost L., Vaillant G., Brun J.M., et al. Effect of insulin treatment on plasma oxidized LDL/LDL-cholesterol ratio in type 2 diabetic patients. Diabetes Metab 2006, 32(6):625-631.
26. Dobiasova M., Frohlich J. The plasma parameter log (TG/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate in apo-B-lipoprotein-depleted plasma. Clin Biochem 2001, 34:583-588.
27. Frohilich J., Dobiasova M. Fractional esterification rate of cholesterol and ratio of triglyceride to HDL-C are powerful predictors of positive finding on coronary angiography. Clin Chem 2003, 49:1873-1880.
28. Nair D., Carrigan T.P., Curtin R.J., Popovic Z.B., Kuzmiak S., Schoenhagen P., et al. Association of total cholesterol/high-density lipoprotein cholesterol ratio with proximal coronary atherosclerosis detected by multislice computed tomography. Prev Cardiol 2009, 12(1):19-26.
29. Christiansen B., Bellostas Muguerza N., Petersen A.M., Kveiborg B., Madsen C.R., Thomas H., et al. Ingestion of broccoli sprouts does not improve endothelial function in humans with hypertension. PLoS One 2010, 5(8):e12461.
30. Kahlon T.S., Chapman M.H., Smith G.E. In vitro binding of bile acids by spinach, kale, brusseles sprouts, broccoli, mustard green, green bell pepper, cabbage and collards. Food Chem 2007, 100:1531-1536.
31. Dunn S.E., LeBlanc G.A. Hypocholesterolemic properties of plant indoles. Inhibition of acyl-CoA:cholesterol acyltransferase activity and reduction of serum LDL/VLDL cholesterol levels by glucobrassicin derivatives. Biochem Pharmacol 1994, 47(2):359-364.
32. LeBlanc G.A., Stuart J.D., Dunn S.E., Baldwin W.S. Effect of the plant compound indole-3-carbinol on hepatic cholesterol homoeostasis. Food Chem Toxicol 1994, 32(7):633-639.
33. Maiyoh G.K., Kuh J.E., Casaschi A., Theriault A.G. Cruciferous indole-3-carbinol inhibits apolipoprotein B secretion in HepG2 cells. J Nutr 2007, 137(10):2185-2189.
34. Menke T., Niklowitz P., de Sousa G., Reinehr T., Andler W. Comparison of coenzyme Q10 plasma levels in obese and normal weight children. Clin Chim Acta 2004, 349(1-2):121-127.
35. Wu L., Noyan M.H., Facci M. Dietary approach to attenuate oxidative stress, hypertension, and inflammation in the cardiovascular system. Proc Natl Acad Sci 2004, 101(18):7094-7099.
36. Galan M.V., Kishan A.A., Silverman A.L. Oral broccoli sprouts for the treatment of Helicobacter pylori infection: a preliminary report. Dig Dis Sci 2004, 49(7-8):1088-1090.